Gordon, Jessica K
Hospital for Special Surgery
3 papers on CoChatORCID 0000-0001-8068-0592
Most cited papers
- Verified
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Rice, L. M., Padilla, C. M., McLaughlin, S. R., Mathes, A., Ziemek, J., Goummih, S., Nakerakanti, S., York, M., Farina, G., Whitfield, M. L., et al. (2015) · Journal of Clinical Investigation
Systemic Sclerosis and Related DiseasesConnective tissue disorders research
Cited by 351
- Verified
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Skaug, B., Khanna, D., Swindell, W. R., Hinchcliff, M. E., Frech, T. M., Steen, V. D., Hant, F. N., Gordon, J. K., Shah, A. A., Zhu, L., et al. (2020) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments
Cited by 179
- Verified
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
Spiera, R. F., Gordon, J. K., Mersten, J. N., Magro, C. M., Mehta, M., Wildman, H. F., Kloiber, S., Kirou, K. A., Lyman, S., & Crow, M. K. (2011) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesConnective tissue disorders research
Cited by 173
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free